UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000016114
Receipt number R000018717
Scientific Title A randomized placebo-controlled study to explore novel immunotherapy for food allergy: Effect of adjunctive TGF-rich food in a rush oral immunotherapy for milk allergy
Date of disclosure of the study information 2015/01/06
Last modified on 2016/10/25 22:09:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized placebo-controlled study to explore novel immunotherapy for food allergy: Effect of adjunctive TGF-rich food in a rush oral immunotherapy for milk allergy

Acronym

Effect of adjunctive TGF-rich food in rush oral immunotherapy for milk allergy

Scientific Title

A randomized placebo-controlled study to explore novel immunotherapy for food allergy: Effect of adjunctive TGF-rich food in a rush oral immunotherapy for milk allergy

Scientific Title:Acronym

Effect of adjunctive TGF-rich food in rush oral immunotherapy for milk allergy

Region

Japan


Condition

Condition

food allergy (milk)

Classification by specialty

Medicine in general Clinical immunology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To test whether TGF-rich food in combination with oral immunotherapy is effective and safe for milk allergy

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Exploratory

Trial characteristics_2

Pragmatic

Developmental phase

Phase I,II


Assessment

Primary outcomes

Change in threshold of oral food challenge test

Key secondary outcomes

Number of adrenaline use for severe induced symptoms


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

Placebo

Stratification

NO

Dynamic allocation

YES

Institution consideration


Blocking

NO

Concealment

Central registration


Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Milk-derived TGF-beta-enriched food

Interventions/Control_2

Oral immunotherapy with milk

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

5 years-old <=

Age-upper limit

15 years-old >=

Gender

Male and Female

Key inclusion criteria

Milk allergy patients definitively diagnosed by oral food challenge with threshold of above 1ml, and 10 ml or less.

Key exclusion criteria

1) Allergy to soy bean or dextrin, which are contained in placebo
2) Poorly controlled bronchial asthma and/or atopic dermatitis (If controlled with optimal pharmaceutical therapy, not excluded)

Target sample size

40


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Takao Fujisawa

Organization

Mie National Hospital

Division name

Allergy Center

Zip code


Address

357 Osato-kubot, Tsu, Mie, Japan

TEL

+81592322531

Email

eosinophilosophy@gmail.com


Public contact

Name of contact person

1st name
Middle name
Last name Mizuho Nagao

Organization

Mie National Hospital

Division name

Institute for Clinical Research

Zip code


Address

357 Osato-kubot, Tsu, Mie, Japan

TEL

+81592322531

Homepage URL


Email

nagaomizuho@mie-m.hosp.go.jp


Sponsor or person

Institute

Mie National Hospital

Institute

Department

Personal name



Funding Source

Organization

Ministry of Health, Labore and Welfar, Japan

Organization

Division

Category of Funding Organization

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor

University of Chiba

Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

国立病院機構三重病院、千葉大学病院、獨協医大病院、国立病院機構下志津病院、群馬大学病院、千葉県子ども病院、あいち小児保健医療総合センター、大阪府立呼吸器アレルギー医療センター、国立病院機構福山医療センター、富山大学病院


Other administrative information

Date of disclosure of the study information

2015 Year 01 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2014 Year 08 Month 20 Day

Date of IRB


Anticipated trial start date

2015 Year 01 Month 06 Day

Last follow-up date

2016 Year 12 Month 31 Day

Date of closure to data entry

2017 Year 03 Month 30 Day

Date trial data considered complete

2017 Year 06 Month 30 Day

Date analysis concluded

2017 Year 09 Month 30 Day


Other

Other related information



Management information

Registered date

2015 Year 01 Month 05 Day

Last modified on

2016 Year 10 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018717